1 Min Read
May 15 (Reuters) - Cleveland Biolabs Inc
* Cleveland Biolabs reports first quarter 2017 financial results and development progress
* Q1 revenue $600,000 versus $800,000
* Qtrly loss per share $0.15 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.